Blog

Home/News/Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials

Fujifilm shares fall after report Avigan not showing clear efficacy in some coronavirus trials

Shares of Fujifilm Holdings Corp fell on Wednesday after Kyodo news reported that so far there has been no clear evidence of efficacy for its drug Avigan in treating the novel coronavirus in some clinical trials.

    

Written by

Peter Zirbes, ESQ. A Full Service Law Office 718 544 6300